Twenty promising life science companies from the Nordic region have been shortlisted to compete in the prestigious Nordic Stars pitch competition at Nordic Life Science Days (NLSDays) 2024. These emerging companies will present their innovations to an audience of investors, industry leaders, and conference delegates at the event in Malmö, held on September 18-19.
The shortlisted competitors are small- and medium-sized private companies from the Nordic countries, engaged in research and development within health, medicine, or life science. Each company will deliver a four-minute pitch, aiming to attract new investors and business partners through both the pitch and the conference’s partnering system.
In addition to potential investor interest, the competitors will vie for a significant prize awarded during the NLSDays closing ceremony. The company deemed to have the highest investment potential by a jury of investors and pharma representatives will receive a prize of 10,000 EUR in cash, in-kind services, and two full-access tickets to NLSDays 2025.
Start-up Loma Therapeutics won Merck's Advance Biotech Grant Program – Nordics, at NLSDays 2023 Nordic Star Pitch Competition.
All applicants were rigorously assessed by an expert panel, which selected the 20 companies to participate at NLSDays. This jury will also judge the pitches at the event. The panel includes: Elena Fernandez Kleinlein – JLABS EMEA Johnson & Johnson, Dr. Sara Kangaspeska – Innovestor, Dr. Markus Dietrich – Hadean Ventures, Inka Mero – Voima Ventures, Dr. Chloé Leprêtre – Servier, Dr. Lovisa Backemar – EIR Ventures, Dr. Marjo Puumalainen – SwedenBIO
“There was great diversity among the applicants, making the selection challenging. Many of the selected companies show high investment potential, and I am eager to meet them at NLSDays to learn more about their technologies,” said Dr. Sara Kangaspeska from Innovestor.
The 20 small- and medium-sized companies selected to present at NLSDays are:
- Probmet
- Loma Therapeutics
- Droplet IV
- DECORADE Therapeutics
- metaLead Therapeutics ApS
- Pephexia Therapeutics ApS
- im.Engine
- Dora Health Ab
- Smart PD Solutions Ltd. / Kiwecare
- Bulbitech AS
- DoMore Diagnostics
- Alder Therapeutics
- Paindrainer AB
- Rarity Bioscience
- BrainLink
- AKIRA Science AB
- BrainZell AB
- Countagen AB
- MyCural Therapeutics
- Intelligent Implants
NLSDays 2024 promises to be an exciting event, highlighting the cutting-edge innovations from the Nordic life science sector and providing a valuable platform for these companies to connect with potential investors and partners.
The industry organisation SwedenBIO works for a competitive life science sector in Sweden. We do this by creating effective interfaces between the sector's various actors, by building knowledge and by giving the industry a strong voice in the public debate. Our more than 330 member companies are active in drug development, biotechnology, medical technology and diagnostics, or are experts in areas such as business development, financing, intellectual property and law.
Powered by Notified